How do mutations benefit severe acute respiratory syndrome coronavirus 2
A glycan controls how SARS-CoV-2’s spike protein opens, study finds
Using simulations, a team of researchers in the U.S. found
Vaccine candidate containing tetanus toxoid potentially protective against SARS-CoV-2
Researchers from Cuba, China, and France have demonstrated the potential
SARS-CoV-2 was in NYC a good month before it was first identified, say researchers
Researchers at Icahn School of Medicine at Mount Sinai in
Orally administered experimental drug halts SARS-CoV-2 replication, prevents infection
Publishing their work in Nature, scientists at the UNC School
Vaccinated mothers may pass on SARS-CoV-2 antibodies to newborns
Even as the ongoing pandemic of coronavirus disease 2019 (COVID-19),
Scientists who discovered SARS just revealed the immune system’s response to COVID-19
In this study, which was published in the journal Frontiers